Key risk factors for recurrence and metastasis include tumor location outside the head and neck, high-grade histological morphology, active mitosis (>5/10HPF), necrosis, and PTCH1-GLI1 gene alteration. This evidence concerns the gene PTCH1 and neoplasm.